Salarius Pharmaceuticals to Report First Quarter 2020 Financial Results

NEXT STORY
Coherus BioSciences Reports First Quarter 2020 Financial Results
PREV STORY
Fluidigm Expands Accessibility of Mass Cytometry and Imaging Mass Cytometry Technology with New Therapeutic Insights Services
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

electroCore, Inc. Announces The Launch of a New Online Shop in the United Kingdom

author_avatar
NASDAQ Market News

HOOKIPA Announces First Patient Dosed in Phase 1/2 Clinical Trial for HB-201 for the Treatment of Human Papillomavirus 16-Positive Cancers

author_avatar
NASDAQ Market News

Fennec Pharmaceuticals Completes Rolling Submission of New Drug Application (NDA) to U.S. Food and Drug Administration for PEDMARK™ and Also Submits Marketing Authorization Application (MAA) to European Medicines Agency

author_avatar
NASDAQ Market News